Back to Top
CA116-003 Screenshot 0
CA116-003 Screenshot 1
Free website generator for mobile apps; privacy policy, app-ads.txt support and more... AppPage.net

About CA116-003

You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.

Similar Apps

Medable Participant App

Medable Participant App

4.4

Today’s rapidly changing healthcare landscape presents new challenges and disruptions to patient...

ZEUS Study App (EX6018-4758)

ZEUS Study App (EX6018-4758)

0.0

This app is specifically intended for study participants in the ZEUS (EX6018-4758)...

I8F-MC-GPHJ PATIENT

I8F-MC-GPHJ PATIENT

0.0

A Phase 3b/4, Randomized Study in Adults w/Obesity or Overweight w/Weight-Related Comorbidities...

NN7769-4532 Participant

NN7769-4532 Participant

0.0

This app is specifically intended for study participants in the Frontier4 (NN7769-4532)...

CA055-026

CA055-026

0.0

This app is specifically intended for study participants in the Bristol Myers...

CA116-001

CA116-001

0.0

You are invited to participate in the Bristol Myers Squibb CA116-001 study....